Usefulness of Serum Carboxy-Terminal Propeptide of Procollagen Type I in Assessment of the Cardioreparative Ability of Antihypertensive Treatment in Hypertensive Patients | Zendy

Begoña López | Zendy; Ramón Querejeta | Zendy; Nerea Varo | Zendy; Arantxa González | Zendy; Mariano Larman | Zendy; José L. Martínez Ubago | Zendy; Javier Dı́ez | Zendy

Open Access

Usefulness of Serum Carboxy-Terminal Propeptide of Procollagen Type I in Assessment of the Cardioreparative Ability of Antihypertensive Treatment in Hypertensive Patients

Author(s) -

Begoña López,

Ramón Querejeta,

Nerea Varo,

Arantxa González,

Mariano Larman,

José L. Martínez Ubago,

Javier Dı́ez

Publication year - 2001

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.104.3.286

Subject(s) - medicine , procollagen peptidase , protein precursor , terminal (telecommunication) , endocrinology , pharmacology , biochemistry , telecommunications , chemistry , computer science , gene

We investigated whether serum concentration of carboxy-terminal propeptide of procollagen type I (PIP), a marker of collagen type I synthesis, can be used to assess the ability of antihypertensive treatment to regress myocardial fibrosis in hypertensive patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research